Coulie Bernard
Pliant Therapeutics, Inc. · President and CEO
Coulie Bernard is listed in filings as President and CEO at Pliant Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2026, including sale activity. Recent filings connect the profile to Pliant Therapeutics, Inc. (PLRX) and Septerna, Inc. (SEPN). The current snapshot covers public activity from Jul 11, 2024 to Apr 17, 2026. Reported amounts are shown as $7.1M to $5.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $587k52.4k shares | SellJan 17, 2025 | $11.20 | $1.12 | |
| $447k38.7k shares | SellJul 10, 2024 | $11.56 | $1.12 |